Latest Insider Transactions at Celanese Corp (CE)
This section provides a real-time view of insider transactions for Celanese Corp (CE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Celanese Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Celanese Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2024
|
Bruce E. Chinn Director |
BUY
Grant, award, or other acquisition
|
Direct |
910
+50.0%
|
-
|
|
Aug 20
2024
|
Scott A Richardson EVP & COO |
SELL
Open market or private sale
|
Direct |
4,675
-6.7%
|
$603,075
$129.41 P/Share
|
|
Aug 19
2024
|
Scott A Richardson EVP & COO |
SELL
Open market or private sale
|
Direct |
4,675
-6.28%
|
$603,075
$129.51 P/Share
|
|
Jul 13
2024
|
Mark Christopher Murray SVP - Acetyls |
SELL
Payment of exercise price or tax liability
|
Direct |
471
-4.06%
|
$65,940
$140.58 P/Share
|
|
May 15
2024
|
Kim K.W. Rucker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,114
+48.77%
|
$173,784
$156.96 P/Share
|
|
May 15
2024
|
David F Hoffmeister Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,114
+50.0%
|
$173,784
$156.96 P/Share
|
|
May 15
2024
|
Jay V Ihlenfeld Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,114
+8.2%
|
$173,784
$156.96 P/Share
|
|
May 15
2024
|
Deborah J. Kissire Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,114
+47.85%
|
$173,784
$156.96 P/Share
|
|
May 15
2024
|
Michael Koenig Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,114
+25.14%
|
$173,784
$156.96 P/Share
|
|
May 15
2024
|
Ganesh Moorthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,114
+40.46%
|
$173,784
$156.96 P/Share
|
|
May 15
2024
|
Edward G Galante Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,114
+6.96%
|
$173,784
$156.96 P/Share
|
|
May 15
2024
|
Timothy Go Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,114
+50.0%
|
$173,784
$156.96 P/Share
|
|
May 15
2024
|
Kathryn Hill Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,114
+9.52%
|
$173,784
$156.96 P/Share
|
|
May 12
2024
|
Deborah J. Kissire Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,777
-94.67%
|
-
|
|
May 12
2024
|
Michael Koenig Director |
SELL
Payment of exercise price or tax liability
|
Direct |
534
-19.51%
|
$84,906
$159.07 P/Share
|
|
May 12
2024
|
Kim K.W. Rucker Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,777
-96.94%
|
-
|
|
May 12
2024
|
William M Brown Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,777
-94.52%
|
-
|
|
May 12
2024
|
Kathryn Hill Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,777
-15.79%
|
-
|
|
Mar 15
2024
|
Scott A Richardson EVP & COO |
SELL
Open market or private sale
|
Direct |
2,000
-2.62%
|
$312,000
$156.49 P/Share
|
|
Mar 14
2024
|
Thomas Francis Kelly SVP, EM |
BUY
Open market or private purchase
|
Direct |
1,400
+2.4%
|
$218,400
$156.69 P/Share
|
|
Mar 14
2024
|
Scott A Richardson EVP & COO |
SELL
Open market or private sale
|
Direct |
2,000
-2.55%
|
$312,000
$156.85 P/Share
|
|
Mar 08
2024
|
Mark Christopher Murray SVP - Acetyls |
BUY
Open market or private purchase
|
Direct |
597
+4.89%
|
$93,132
$156.43 P/Share
|
|
Feb 15
2024
|
Mark Christopher Murray SVP - Acetyls |
SELL
Payment of exercise price or tax liability
|
Direct |
124
-1.11%
|
$18,600
$150.82 P/Share
|
|
Feb 15
2024
|
Scott A Richardson EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,134
-9.4%
|
$1,220,100
$150.82 P/Share
|
|
Feb 15
2024
|
Scott A Richardson EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
20,728
+19.32%
|
-
|
|
Feb 15
2024
|
Lori Ryerkerk Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,747
-14.77%
|
$4,012,050
$150.82 P/Share
|
|
Feb 15
2024
|
Lori Ryerkerk Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
61,828
+25.46%
|
-
|
|
Feb 15
2024
|
Ashley B Duffie SVP & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
969
-6.65%
|
$145,350
$150.82 P/Share
|
|
Feb 15
2024
|
Ashley B Duffie SVP & GC |
BUY
Grant, award, or other acquisition
|
Direct |
3,460
+19.19%
|
-
|
|
Feb 15
2024
|
Thomas Francis Kelly SVP, EM |
SELL
Payment of exercise price or tax liability
|
Direct |
4,908
-8.11%
|
$736,200
$150.82 P/Share
|
|
Feb 15
2024
|
Thomas Francis Kelly SVP, EM |
BUY
Grant, award, or other acquisition
|
Direct |
13,366
+18.09%
|
-
|
|
Feb 15
2024
|
Chuck Kyrish SVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,560
-21.29%
|
$234,000
$150.82 P/Share
|
|
Feb 15
2024
|
Chuck Kyrish SVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,460
+32.07%
|
-
|
|
Feb 15
2024
|
Aaron M Mc Gilvray Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
371
-5.96%
|
$55,650
$150.82 P/Share
|
|
Feb 15
2024
|
Aaron M Mc Gilvray Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,152
+15.61%
|
-
|
|
Dec 01
2023
|
Lori Ryerkerk Chairman and CEO |
SELL
Bona fide gift
|
Direct |
150
-0.13%
|
-
|
|
Dec 01
2023
|
Ganesh Moorthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
525
+50.0%
|
-
|
|
Dec 01
2023
|
Scott A Richardson EVP & COO |
SELL
Bona fide gift
|
Direct |
495
-0.75%
|
-
|
|
Jul 13
2023
|
Mark Christopher Murray SVP - Acetyls |
SELL
Payment of exercise price or tax liability
|
Direct |
470
-4.05%
|
$57,340
$122.13 P/Share
|
|
May 19
2023
|
Thomas Francis Kelly SVP, EM |
BUY
Open market or private purchase
|
Direct |
2,000
+4.07%
|
$214,000
$107.29 P/Share
|
|
May 12
2023
|
Jean S Blackwell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,777
+13.83%
|
$174,146
$98.46 P/Share
|
|
May 12
2023
|
William M Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,777
+48.59%
|
$174,146
$98.46 P/Share
|
|
May 12
2023
|
Edward G Galante Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,777
+11.43%
|
$174,146
$98.46 P/Share
|
|
May 12
2023
|
Kathryn Hill Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,777
+13.64%
|
$174,146
$98.46 P/Share
|
|
May 12
2023
|
David F Hoffmeister Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,777
+3.41%
|
$174,146
$98.46 P/Share
|
|
May 12
2023
|
Jay V Ihlenfeld Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,777
+13.53%
|
$174,146
$98.46 P/Share
|
|
May 12
2023
|
Deborah J. Kissire Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,777
+48.63%
|
$174,146
$98.46 P/Share
|
|
May 12
2023
|
Michael Koenig Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,777
+39.37%
|
$174,146
$98.46 P/Share
|
|
May 12
2023
|
Kim K.W. Rucker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,777
+49.22%
|
$174,146
$98.46 P/Share
|
|
May 12
2023
|
Mark Christopher Murray SVP - Acetyls |
BUY
Open market or private purchase
|
Direct |
1,008
+8.0%
|
$101,808
$101.69 P/Share
|